{"id":"W2151492920","doi":"10.1016/s1474-4422(14)70028-6","title":"Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono; Bayer HealthCare; Merck KGaA","keywords":"Medicine; Clinical endpoint; Placebo; Internal medicine; Population; Clinical trial; Double blind; Multiple sclerosis; Adverse effect; Phases of clinical research; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003198331,0.003468068,0.006732539,0.0008680464,0.000906374,0.001596599,0.001571935,0.004034141,0.009787082],"category_scores_gemma":[0.002999448,0.001124499,0.003154852,0.0008215115,0.001588311,0.002534839,0.0005694968,0.004547577,0.001952289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009196649,"about_ca_system_score_gemma":0.001555778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001157474,"about_ca_topic_score_gemma":0.002196771,"domain_scores_codex":[0.9990012,0.0004729757,0.00009316971,0.0002170334,0.00009023604,0.0001254286],"domain_scores_gemma":[0.9987509,0.0004167313,0.0002646614,0.000104574,0.00009928968,0.0003637637],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.984409,0.00229514,0.0001727927,0.001105516,0.001090657,0.00003428708,0.00004179255,0.0001502141,0.001367875,0.0001216749,0.001059969,0.008151096],"study_design_scores_gemma":[0.9891499,0.009853038,0.0002315399,0.00002171481,0.000259014,0.00001392465,0.000006354689,0.0000850806,0.00006843862,0.00006340642,0.0002405956,0.000007028086],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9391706,0.03288336,0.00244153,0.002587951,0.004098904,0.0107058,0.003502242,0.0006382581,0.00397132],"genre_scores_gemma":[0.9353676,0.0180167,0.006482065,0.004639073,0.002644038,0.02067979,0.002901562,0.0001214181,0.009147727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009787082,"threshold_uncertainty_score":0.03274107,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1721700253737474,"score_gpt":0.3659181265864245,"score_spread":0.1937481012126771,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}